{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T20:12:12Z","timestamp":1792872732754,"version":"4.5.0"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:00:00Z","timestamp":1611187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Aristolactam I (ALI) is an active component derived from some Traditional Chinese medicines (TCMs), and also the important metabolite of aristolochic acid. Long-term administration of medicine-containing ALI was reported to be related to aristolochic acid nephropathy (AAN), which was attributed to ALI-induced nephrotoxicity. However, the toxic mechanism of action involved is still unclear. Recently, pathogenic ferroptosis mediated lipid peroxidation was demonstrated to cause kidney injury. Therefore, this study explored the role of ferroptosis induced by mitochondrial iron overload in ALI-induced nephrotoxicity, aiming to identify the possible toxic mechanism of ALI-induced chronic nephropathy. Our results showed that ALI inhibited HK-2 cell activity in a dose-dependent manner and significantly suppressed glutathione (GSH) levels, accompanying by significant increases in intracellular 4-hydroxynonenal (4-HNE) and intracellular iron ions. Moreover, the ALI-mediated cytotoxicity could be reversed by deferoxamine mesylate (DFO). Compared with other inhibitors, Ferrostatin-1 (Fer-1), a ferroptosis inhibitor, obviously alleviated ALI-induced cytotoxicity. Furthermore, we have shown that ALI could remarkably increase the levels of superoxide anion and ferrous ions in mitochondria, and induce mitochondrial damage and condensed mitochondrial membrane density, the morphological characteristics of ferroptosis, all of which could be reversed by DFO. Interestingly, ALI dose-dependently inhibited these protein contents of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), and glutathione peroxidase 4 (GPX4), which could be partly rescued by Tin-protoporphyrin IX (SnPP) and mitoTEMPO co-treatment. In conclusion, our results demonstrated that mitochondrial iron overload-mediated antioxidant system inhibition would assist ALI-induced ferroptosis in renal tubular epithelial cells, and Nrf2-HO-1\/GPX4 antioxidative system could be an important intervention target to prevent medicine containing ALI-induced nephropathy.<\/jats:p>","DOI":"10.3389\/fphar.2020.624529","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T05:00:02Z","timestamp":1611205202000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":82,"title":["Mitochondrial Iron Overload-Mediated Inhibition of Nrf2-HO-1\/GPX4 Assisted ALI-Induced Nephrotoxicity"],"prefix":"10.3389","volume":"11","author":[{"given":"Hui-Fang","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Xin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning-Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hao","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Shu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Zhen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Ling","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Guang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng-Chun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.chembiol.2020.03.011","article-title":"Breakdown of an ironclad defense system: the critical role of NRF2 in mediating ferroptosis","volume":"27","author":"Anandhan","year":"2020","journal-title":"Cell Chem. Biol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.tox.2019.03.013","article-title":"Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models","volume":"420","author":"Bastek","year":"2019","journal-title":"Toxicology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ki.2012.264","article-title":"Probenecid prevents acute tubular necrosis in a mouse model of aristolochic acid nephropathy","volume":"82","author":"Baudoux","year":"2012","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","article-title":"Mitochondrial energetics in the kidney","volume":"13","author":"Bhargava","year":"2017","journal-title":"Nat. Rev. Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell. Mol. Life Sci"},{"key":"B6","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2008.129","article-title":"Aristolochic acid nephropathy: a worldwide problem","volume":"74","author":"Debelle","year":"2008","journal-title":"Kidney Int"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu. Rev. Pharmacol. Toxicol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.kint.2017.05.034","article-title":"The hallmarks of mitochondrial dysfunction in chronic kidney disease","volume":"92","author":"Galvan","year":"2017","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e4000","DOI":"10.1136\/bmj.e4000","article-title":"Aristolochic acid nephropathy","volume":"344","author":"G\u00f6kmen","year":"2012","journal-title":"BMJ"},{"key":"B11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000346180","article-title":"Development of a chronic kidney disease model in C57BL\/6 mice with relevance to human pathology","volume":"3","author":"Huang","year":"2013","journal-title":"NNE"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18020297","article-title":"An integrated view of aristolochic acid nephropathy: update of the literature","volume":"18","author":"Jadot","year":"2017","journal-title":"Int. J. Mol. Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194968","article-title":"Programmed cell-death by ferroptosis: antioxidants as mitigators","volume":"20","author":"Kajarabille","year":"2019","journal-title":"Int. J. Mol. Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jep.2017.12.013","article-title":"Zhen-Wu-tang ameliorates adenine-induced chronic renal failure in rats: regulation of the canonical Wnt4\/beta-catenin signaling in the kidneys","volume":"219","author":"La","year":"2018","journal-title":"J. Ethnopharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1089\/ars.2016.6659","article-title":"Heme oxygenase-1 in kidney health and disease","volume":"25","author":"Lever","year":"2016","journal-title":"Antioxidants Redox Signal"},{"key":"B16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1159\/000446854","article-title":"Expression of renal aquaporins in aristolochic acid I and Aristolactam I-induced nephrotoxicity","volume":"133","author":"Li","year":"2016","journal-title":"Nephron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.tiv.2010.03.012","article-title":"Toxicities of aristolochic acid I and aristololactam I in cultured renal epithelial cells","volume":"24","author":"Li","year":"2010","journal-title":"Toxicol. Vitro"},{"key":"B18","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fphar.2017.00215","article-title":"Medicinally used Asarum species: high-resolution LC-MS analysis of aristolochic acid analogs and in vitro toxicity screening in HK-2 cells","volume":"8","author":"Michl","year":"2017","journal-title":"Front. Pharmacol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","article-title":"Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases","volume":"1863","author":"Nakamura","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj"},{"key":"B20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1021\/tx200333g","article-title":"Aristolochic acid I metabolism in the isolated perfused rat kidney","volume":"25","author":"Priestap","year":"2012","journal-title":"Chem. Res. Toxicol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","article-title":"Role of GPX4 in ferroptosis and its pharmacological implication","volume":"133","author":"Seibt","year":"2019","journal-title":"Free Radic. Biol. Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3389\/fnins.2020.00267","article-title":"Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases","volume":"14","author":"Song","year":"2020","journal-title":"Front. Neurosci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s11255-019-02335-7","article-title":"Ferroptosis and kidney diseases","volume":"52","author":"Tang","year":"2020","journal-title":"Int. Urol. Nephrol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jep.2014.08.035","article-title":"Dahuang Fuzi Decoction ameliorates tubular epithelial apoptosis and renal damage via inhibiting TGF-\u03b21-JNK signaling pathway activation in vivo","volume":"156","author":"Tu","year":"2014","journal-title":"J. Ethnopharmacol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/hep.29117","article-title":"Characterization of ferroptosis in murine models of hemochromatosis","volume":"66","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"151058","DOI":"10.1016\/j.ejcb.2019.151058","article-title":"Mitochondria regulation in ferroptosis","volume":"99","author":"Wang","year":"2020","journal-title":"Eur. J. Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fphar.2020.01035","article-title":"Uncovering the complexity mechanism of different formulas treatment for rheumatoid arthritis based on a novel network Pharmacology model","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s10495-017-1369-z","article-title":"Relaxin attenuates aristolochic acid induced human tubular epithelial cell apoptosis in vitro by activation of the PI3K\/Akt signaling pathway","volume":"22","author":"Xie","year":"2017","journal-title":"Apoptosis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"108917","DOI":"10.1016\/j.biopha.2019.108917","article-title":"Protective role of relaxin in a mouse model of aristolochic acid nephropathy","volume":"115","author":"Yang","year":"2019","journal-title":"Biomed. Pharmacother"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10495-014-0996-x","article-title":"Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aritolochic acid nephropathy model","volume":"19","author":"Zeng","year":"2014","journal-title":"Apoptosis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep12936","article-title":"Metabolomics analysis reveals the association between lipid abnormalities and oxidative stress, inflammation, fibrosis and Nrf2 dysfunction in aristolochic acid-induced nephropathy","volume":"5","author":"Zhao","year":"2015","journal-title":"Sci. Rep"},{"key":"B34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1681\/ASN.2008111133","article-title":"Activation of p53 promotes renal injury in acute aristolochic acid nephropathy","volume":"21","author":"Zhou","year":"2010","journal-title":"J. Am. Soc. Nephrol"}],"updated-by":[{"DOI":"10.3389\/fphar.2025.1734058","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:00:00Z","timestamp":1765756800000}}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.624529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T09:41:41Z","timestamp":1765791701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2020.624529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":34,"alternative-id":["10.3389\/fphar.2020.624529"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.624529","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,21]]},"article-number":"624529"}}